DESCP Stock Latest News
Company AnnouncementsScancell clears share consolidation as it readies AIM trading and deal push1M ago
Company AnnouncementsScancell Issues Shares Ahead of Consolidation and Publishes 2026 Annual Report1M ago
Company AnnouncementsScancell Bolsters Cancer Immunotherapy Push With Nasdaq Move and $75m Funding1M ago
Company AnnouncementsScancell Sets Vote on Neuphoria Merger and 10-for-1 Share Consolidation1M ago
Company AnnouncementsScancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 31M ago
Company AnnouncementsScancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference2M agoCompany AnnouncementsScancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+3M ago
Company AnnouncementsScancell Raises £15.7m After Oversubscribed Retail Offer and UK Placing3M ago
Company AnnouncementsScancell and Neuphoria in all-share merger backed by $89m financing for melanoma trial3M ago
Company AnnouncementsScancell upsizes oversubscribed £13m UK placing to extend funding runway4M ago
Company AnnouncementsScancell launches discounted UK share placing to fund Phase 3 melanoma trial4M ago
Company AnnouncementsScancell launches retail offer and placing to extend cash runway into 20274M agoCompany AnnouncementsScancell to Merge with Neuphoria and Secure Up to $89m for Phase 3 Melanoma Trial4M ago
Company AnnouncementsScancell in advanced talks on Neuphoria reverse merger and Nasdaq listing4M ago
Company AnnouncementsScancell Wins FDA Fast Track for Melanoma Vaccine as Phase 2 Data Strengthen6M ago
Company AnnouncementsScancell Taps Veteran Biotech Financier as Interim CFO Amid iSCIB1+ Push7M ago
Company AnnouncementsScancell Holdings Charts Risky but Promising Phase III Path9M ago
Company AnnouncementsScancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance9M ago
Company AnnouncementsScancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data9M agoCompany AnnouncementsScancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances10M ago



